Lisa M. DeFrancesco - 02 Oct 2024 Form 3 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role: VP, IR and Corp Strategy
Signature: /s/ Lisa M. DeFrancesco
Issuer symbol: LXRX
Transactions as of: 02 Oct 2024
Net transactions value: $0
Form type: 3
Filing time: 07 Oct 2024, 16:58:38 UTC
Previous filing: 04 Jan 2022
Next filing: 18 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	LXRX	Common Stock						0	02 Oct 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	LXRX	Stock Option (Right to Buy)							02 Oct 2024	Common Stock	230,000	$1.01	Direct	F1
holding	LXRX	Restricted Stock Units							02 Oct 2024	Common Stock	74,020		Direct	F2, F3
holding	LXRX	Stock Option (Right to Buy)							02 Oct 2024	Common Stock	74,020	$2.15	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (11/13/2024) and vests 1/48th per month for each month of service thereafter.
F2	Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
F3	Each restricted stock unit represents a contingent right to receive one share of common stock.
F4	Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.